APA (7th ed.) Citation

L, P., AS, D., EM, C., MH, S., AP, C., N, D. L. H., . . . V, G. (2024). Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. Annals of hematology, 103(11), 4537. https://doi.org/10.1007/s00277-024-05906-6

Chicago Style (17th ed.) Citation

L, Pérez-Lamas, et al. "Outcomes of Chronic Myeloid Leukemia Patients After Therapeutic Failure to Conventional Tyrosine Kinase Inhibitors and Asciminib." Annals of Hematology 103, no. 11 (2024): 4537. https://doi.org/10.1007/s00277-024-05906-6.

MLA (9th ed.) Citation

L, Pérez-Lamas, et al. "Outcomes of Chronic Myeloid Leukemia Patients After Therapeutic Failure to Conventional Tyrosine Kinase Inhibitors and Asciminib." Annals of Hematology, vol. 103, no. 11, 2024, p. 4537, https://doi.org/10.1007/s00277-024-05906-6.